SLDX OTC
Stella Diagnostics Inc.
1W: +24.1%
1M: +24.1%
3M: -3.1%
YTD: -35.4%
1Y: -50.0%
3Y: -90.9%
5Y: -99.0%
$0.01
+0.00 (+24.07%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$1M
+91.1% ▲
Net Income
-$1M
+78.3% ▲
EPS (Diluted)
$-0.00
+83.7% ▲
EBITDA
-$1M
+78.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $110K | $598K | $252K | $0 | $0 |
| SG&A Expenses | $55K | $4M | $2M | $11M | $1M |
| Operating Expenses | $165K | $5M | $2M | $11M | $1M |
| Operating Income | -$165K | -$5M | -$2M | -$11M | -$1M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $13K | $304K | $311K | $0 | $0 |
| Income Before Tax | -$262K | -$17M | -$6M | -$6M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$262K | -$17M | -$6M | -$6M | -$1M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.17 | $-0.03 | $-0.02 | $-0.00 |
| EBITDA | -$43K | -$16M | -$5M | -$6M | -$1M |
| Shares Outstanding | 96M | 96M | 165M | 300M | 402M |